CRBU Q1 2021 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CRBUCaribou Biosciences, Inc.

$181M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-6.8% YoY

Gross Profit

-$9M-540.9% margin

Operating Income

-$13M-830.7% margin

Net Income

-$13M-829.7% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

+61.2%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$20M

Stock-Based Comp.

$343,000

Balance Sheet

Total Assets

$168M

Total Liabilities

$204M

Stockholders' Equity

-$36M

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-6.8%
Gross Profit	-$9M	$2M	-604.4%
Operating Income	-$13M	-$10M	-26.3%
Net Income	-$13M	-$10M	-34.3%